Make Better Decisions

  • Analyze global market entry opportunities
  • Obtain formulation and manufacturing information
  • Drug patents in 130+ countries
➤ Start Trial

or, See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Boehringer Ingelheim
Healthtrust
QuintilesIMS
Express Scripts
Argus Health
Farmers Insurance
Novartis
AstraZeneca
Baxter
Medtronic

Generated: January 23, 2018

DrugPatentWatch Database Preview

ATROPINE SULFATE ANSYR PLASTIC SYRINGE Drug Profile

« Back to Dashboard

When do Atropine Sulfate Ansyr Plastic Syringe patents expire, and when can generic versions of Atropine Sulfate Ansyr Plastic Syringe launch?

Atropine Sulfate Ansyr Plastic Syringe is a drug marketed by Hospira and is included in one NDA.

The generic ingredient in ATROPINE SULFATE ANSYR PLASTIC SYRINGE is atropine sulfate. There are twenty-three drug master file entries for this compound. Six suppliers are listed for this compound. Additional details are available on the atropine sulfate profile page.

US Patents and Regulatory Information for ATROPINE SULFATE ANSYR PLASTIC SYRINGE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Hospira ATROPINE SULFATE ANSYR PLASTIC SYRINGE atropine sulfate SOLUTION;INTRAVENOUS, INTRAMUSCULAR, SUBCUTANEOUS, ENDOTRACHEAL 021146-002 Jul 9, 2001 RX Yes Yes ➤ Subscribe ➤ Subscribe ➤ Subscribe
Hospira ATROPINE SULFATE ANSYR PLASTIC SYRINGE atropine sulfate SOLUTION;INTRAVENOUS, INTRAMUSCULAR, SUBCUTANEOUS, ENDOTRACHEAL 021146-001 Jul 9, 2001 RX Yes Yes ➤ Subscribe ➤ Subscribe ➤ Subscribe
Hospira ATROPINE SULFATE ANSYR PLASTIC SYRINGE atropine sulfate SOLUTION;INTRAVENOUS, INTRAMUSCULAR, SUBCUTANEOUS, ENDOTRACHEAL 021146-003 Jul 9, 2001 RX Yes Yes ➤ Subscribe ➤ Subscribe ➤ Subscribe
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Colorcon
Fish and Richardson
Cerilliant
Deloitte
Johnson and Johnson
Mallinckrodt
Julphar
Cantor Fitzgerald
Covington

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot